ArticleOncotarget2017

Targeting BCR-ABL+ stem/progenitor cells and BCR-ABL-T315I mutant cells by effective inhibition of the BCR-ABL-Tyr177-GRB2 complex.

Min Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.